Severe hypertriglyceridemia and recurrent pancreatitis in a girl with type Ia glycogen storage disease and type III hyperlipoproteinemia

American Journal of Medical Genetics, Part A

Volumn 149, Issue 11, 2009, Pages 2557-2559

  Vivatrat, N ^a   Barshop, B A ^a   Jones, K L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN GLUCURONIDE; DIAZOXIDE; GLUCOSE; INSULIN; LACTIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL PAIN; ACUTE PANCREATITIS; CASE REPORT; CHILD; CHOLESTEROL BLOOD LEVEL; DIAGNOSTIC TEST; DISEASE COURSE; FEMALE; GENETIC ANALYSIS; GENOTYPE; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 1A; HEPATOMEGALY; HOMOZYGOSITY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERLIPOPROTEINEMIA TYPE 3; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; LETTER; LIVER BIOPSY; PANCREATITIS; PHENOTYPE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; VOMITING;

APOLIPOPROTEINS E; BIOPSY; CHILD, PRESCHOOL; FEMALE; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; HYPERLIPOPROTEINEMIA TYPE III; HYPERTRIGLYCERIDEMIA; INFANT; LIPIDS; LIVER; LIVER TRANSPLANTATION; PANCREATITIS, CHRONIC; PROCETOFEN; RECURRENCE;

EID: 70449397292     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.33046     Document Type: Letter

References (19)

1. Bandasma RHJ, Prinsen RH, van der Velden MdS, Rake JP, Boer T, Smit GPA, Reijngoud DJ, Kuipers F. 2008. Increased de novo lipid synthesis and delayed conversion of large VLDL into IDL particles contribute to hyperlipidemia in glycogen storage disease type 1A. Pediatr Res 63:702-707.
2. Brunzell JD. 2007. Clinical practice: Hypertriglyceridemia. N Engl J Med 357:1009-1017.
3. Chou JY. 2001. The molecular basis of type 1 glycogen storage diseases. Curr Mol Med 1:25-44. (Pubitemid 33772968)
4. Davignon J, Gregg RE, Sing CF. 1988. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1-21.
5. Forget PP, Fernandes J, Haverkamp Begemann P. 1974. Triglyceride clearing in glycogen storage disease. Pediatr Res 8:114-119.
6. Geberhinot T, Alger S, McKiernan P, Packard C, Caslake M, Elias E, Cramb R. 2007. Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III, and IX. J Inherited Metab Dis 30:406.
7. Greene HL, Swift LL, Knapp HR. 1991. Hyperlipidemia and fatty acid composition in patients treated for type IA glycogen storage disease. J Pediatr 119:398-403.
8. Kikuchi M, hasegwa K, Handa I, Watabe M, Narisawa K, Tada K. 1991. Chronic pancreatitis in a child with glycogen storage disease type 1. Eur J Pediatr 150:852-853.
9. Lee PJ, Celermajer DS, Robinson J, McCarthy SN, Betteridge DJ, Leonard JV. 1994. Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a. Atherosclerosis. 110:95-100. (Pubitemid 24312432)
10. Levy E, Thibault LA, Roy CC, Bendayan M, Lepage G, Letarte J. 1988. Circulating lipids and lipoproteins in glycogen storage disease type I with nocturnal intragastric feeding. J Lipid Res 29:215-226. (Pubitemid 18069279)
11. Levy E, Thibault L, Roy CC, Letarte J, Lambert M, Seidman EG. 1990. Mechanisms of hypercholesterolaemia in glycogen storage disease type I: Defective metabolism of low density lipoprotein in cultured skin fibroblasts. Eur J Clin Invest 20:253-260. (Pubitemid 20189320)
12. Mahley RW. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
13. Mahley RW, Ji ZS. 1999. Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 40:1-16.
14. Mahley RW, Rall SC Jr. 1995. Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Reaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 7th edition. New York: McGraw Hill. pp. 1953-1980.
15. Mahley RW, Huang Y, Rall SC Jr. 1999. Pathogenesis of type III hyperliporoteinemia (dysbetalipoproteinemia): Questions, quandaries, and paradoxes. J Lipid Res 40:1933-1949. (Pubitemid 29523420)
16. Michaels VV, Beaudet AL. 1980. Hemorrhagic pancreatitis in a patient with glycogen storage disease type 1. Clin Genet 17:220-222. (Pubitemid 10062832)
17. Schaefer EJ, Gregg RE, Ghisellli G, Forte TM, Ordovas JM, Zech LA, Brewer HB Jr. 1986. Familial apolipoprotein E deficiency. J Clin Invest 78: 1206-1219.
18. Smit GP, Rake JP, Akman HO, DiMauro S. 2006. The glycogen storage diseases and related disorders. In: Fernandes J, Saudubray JM, van den Berghe G, Walter JH, editors. Inborn metabolic diseases: Diagnosis and treatment. Wurzburg, Germany: Springer. pp. 101-116.
19. Ubels FL, Rake JP, Slaets JP, Smit GP, Smit AJ. 2002. Is glycogen storage disease 1a associated with atherosclerosis? Eur J Pediatr 161: S62-S64.